- To adopt the Statement of Income and Balanse Sheet for the parent company and the Group for the year of 2005.
- That the total deficit of SEK -20,853,155 shall be balanced against the share premium reserve, which will be reduced by an equivalent amount.
- To discharge the Board of Directors and the Chief Executive Officer from liability.
- That the Board of Directors shall consist of six regular members and no alternatives.
- To re-elect the following Directors:
Christer Fåhraeus
Lars Gatenbeck
Niels Freiesleben
Per Sjöberg
- And to elect the following Directors to the Board:
Paula Treutiger
Sven-Åke Henningsson
- To elect Lars Gatenbeck as the Chairman of the Board.
- That the remuneration to the Chairman of the Board shall amount to SEK 140,000 (100,000). The remuneration to other directors shall amount to SEK 70,000 (50,000) each, in total SEK 350,000 (250,000). Remuneration to the auditors shall be paid on a current account basis.
- To make changes in the Articles of Association in accordance with the Board's proposal. The changes were caused by the issuing of a new Swedish Company Act.
- To approve the Board of Directors' recommendation to resolve to issue a maximum of 3,000,000 shares, whereby the share capital would increase by a maximum of SEK 450,000. This authorization shall remain in force until the next Annual General Meeting. If the authorization is fully implemented, there will be a maximum of 12.6 percent dilution of share capital.
The General Annual Meeting's complete decisions as accounted for above are available at the company address, Ideon Science Park in Lund, and are sent to those share holders who request it.
CellaVision AB (publ)
Board of Directors
Read More: